M. John Gill

28.9k total citations · 1 hit paper
395 papers, 11.3k citations indexed

About

M. John Gill is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, M. John Gill has authored 395 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Infectious Diseases, 143 papers in Epidemiology and 134 papers in Virology. Recurrent topics in M. John Gill's work include HIV/AIDS Research and Interventions (171 papers), HIV Research and Treatment (131 papers) and HIV/AIDS drug development and treatment (100 papers). M. John Gill is often cited by papers focused on HIV/AIDS Research and Interventions (171 papers), HIV Research and Treatment (131 papers) and HIV/AIDS drug development and treatment (100 papers). M. John Gill collaborates with scholars based in Canada, United States and United Kingdom. M. John Gill's co-authors include Hartmut B. Krentz, Christopher Power, HB Krentz, Andrew Phillips, Jonathan A C Sterne, Amy C. Justice, Deirdre L. Church, Peter Reiss, Margaret May and Antonella d’Arminio Monforte and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

M. John Gill

377 papers receiving 10.9k citations

Hit Papers

Prognosis of HIV-1-infect... 2002 2026 2010 2018 2002 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M. John Gill 6.5k 4.2k 3.9k 2.2k 731 395 11.3k
Matthias Cavassini 7.8k 1.2× 5.0k 1.2× 3.7k 0.9× 3.0k 1.4× 1.1k 1.5× 367 11.8k
Alexandra Calmy 6.5k 1.0× 3.8k 0.9× 3.2k 0.8× 3.3k 1.5× 801 1.1× 305 10.1k
Pietro Vernazza 9.7k 1.5× 6.4k 1.5× 4.4k 1.1× 1.9k 0.9× 741 1.0× 222 12.9k
Melanie Thompson 10.4k 1.6× 7.4k 1.7× 3.6k 0.9× 2.5k 1.2× 891 1.2× 112 12.9k
Robert T. Schooley 8.2k 1.3× 6.5k 1.5× 3.6k 0.9× 1.5k 0.7× 627 0.9× 67 11.9k
Stefano Vella 10.4k 1.6× 8.2k 1.9× 3.5k 0.9× 2.2k 1.0× 1.1k 1.5× 247 13.6k
Eric S. Daar 7.3k 1.1× 7.2k 1.7× 2.9k 0.7× 2.5k 1.2× 756 1.0× 239 11.5k
Manuel Battegay 8.4k 1.3× 4.4k 1.0× 5.2k 1.3× 2.8k 1.3× 1.4k 1.9× 437 14.7k
Ann C. Collier 9.1k 1.4× 9.1k 2.1× 3.3k 0.8× 3.0k 1.4× 595 0.8× 256 14.9k
David Katzenstein 11.5k 1.8× 9.5k 2.2× 3.6k 0.9× 1.7k 0.8× 676 0.9× 281 15.2k

Countries citing papers authored by M. John Gill

Since Specialization
Citations

This map shows the geographic impact of M. John Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. John Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. John Gill more than expected).

Fields of papers citing papers by M. John Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. John Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. John Gill. The network helps show where M. John Gill may publish in the future.

Co-authorship network of co-authors of M. John Gill

This figure shows the co-authorship network connecting the top 25 collaborators of M. John Gill. A scholar is included among the top collaborators of M. John Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. John Gill. M. John Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, Paul M. K., Frank van der Meer, Tarah Lynch, et al.. (2025). Apollo: a comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cell. Nature Communications. 16(1). 5783–5783.
2.
Davy-Méndez, Thibaut, Sonia Napravnik, Brenna Hogan, et al.. (2025). Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018. Clinical Infectious Diseases. 81(4). 806–814.
3.
Saeed, Sahar, Erica E. M. Moodie, Joseph Cox, et al.. (2024). Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infectious Diseases. 11(5). ofae239–ofae239. 3 indexed citations
4.
Hudgens, Michael G., Haidong Lu, Stephen R. Cole, et al.. (2023). Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. American Journal of Epidemiology. 192(8). 1341–1349. 1 indexed citations
5.
Hossmann, Stefanie, Suzanne M Ingle, Hajra Okhai, et al.. (2023). HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis. The Lancet HIV. 10(11). e733–e741. 52 indexed citations
7.
Gill, M. John, HB Krentz, Brenda Beckthold, et al.. (2023). COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy. Scientific Reports. 13(1). 20610–20610. 2 indexed citations
8.
Kasaie, Parastu, Elizabeth Humes, Jinbing Zhang, et al.. (2021). Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States. Annals of Epidemiology. 65. 46–55. 7 indexed citations
9.
Rebeiro, Peter F., Peter F. Rebeiro, Cathy A. Jenkins, et al.. (2019). LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care. Open Forum Infectious Diseases. 6(Supplement_2). S996–S997. 13 indexed citations
10.
Yanik, Elizabeth L., Raúl Ulises Hernández‐Ramírez, Qin Li, et al.. (2018). Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. JAIDS Journal of Acquired Immune Deficiency Syndromes. 78(5). 499–504. 13 indexed citations
11.
Lang, Raynell, Ron Read, Hartmut B. Krentz, et al.. (2018). Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study. BMC Infectious Diseases. 18(1). 125–125. 18 indexed citations
12.
Fujiwara, Esther, et al.. (2015). Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV). Journal of Clinical and Experimental Neuropsychology. 37(7). 733–750. 11 indexed citations
13.
Probst, Vincent, Frédéric Sacher, Nicolas Derval, et al.. (2013). Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients. EP Europace. 16(6). 908–913. 1 indexed citations
14.
Kowalska, Justyna, Nina Friis‐Møller, Ole Kirk, et al.. (2011). The Coding Causes of Death in HIV (CoDe) Project. Epidemiology. 22(4). 516–523. 111 indexed citations
15.
Gill, M. John, et al.. (2005). An Evaluation of Motion JPEG 2000 for Video Archiving. Archiving Conference. 2(1). 237–243. 2 indexed citations
16.
Krentz, Hartmut B., M. Christopher Auld, & M. John Gill. (2003). The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.. PubMed. 169(2). 106–10. 54 indexed citations
17.
Church, Deirdre L., et al.. (1997). Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV-1 infection. HIV/GI Research Study Group.. PubMed. 52(1). 31–4. 10 indexed citations
18.
Gill, M. John, et al.. (1991). Five cases of erroneously diagnosed HIV infection.. PubMed Central. 145(12). 1593–5. 5 indexed citations
19.
Gill, M. John. (1975). The Use of Attractive Fixed Points in Accelerating the Convergence of Limit-Periodic Continued Fractions. Proceedings of the American Mathematical Society. 47(1). 119–119. 3 indexed citations
20.
Fendall, N. R. E. & M. John Gill. (1970). Establishing family planning services in Kenya.. PubMed. 85(2). 131–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026